APIDRA 100 units/ml, solution for injection in a vial bottle
Active ingredients: Insulin glulisine
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottleintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- APIDRA 100 Unités/ml, solution injectable en flacon
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- SANOFI AVENTIS (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Mar 2006
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65554613CIP73651809CIP133400936518094Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INSULINE GLULISINEsolution | 100 unités · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.